A Phase II Study of Gemcitabine and Capecitabine for Treatment Resistant, Metastatic Colorectal Cancer
Status:
Completed
Trial end date:
2014-05-01
Target enrollment:
Participant gender:
Summary
The present study aims to investigate the efficacy and safety of the combination of
capecitabine and gemcitabine in heavily pre-treated, treatment resistant metastatic
colorectal cancer.